Clinical Trials
2 trialsNCT00458523 2013-08-12
Alemtuzumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia in Partial Remission or Complete Remission
National Cancer Institute (NCI)
Phase 2 Completed
NCT01653613 2013-07-10
Studying Genes in Samples From Younger Patients With Acute Lymphoblastic Leukemia
National Cancer Institute (NCI)
Unknown